AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34403911 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 intravenously on day 1 plus erlotinib 150 mg/day orally on day 2-16 every 21 days
Number of subjects: 45
Study 33460575 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral strength training of the less affected wrist extensors
Number of subjects: 26
Study 33460575 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 26
Study 33315586 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume injection without corticosteroids (50 mL saline and lidocaine)
Number of subjects: 80
Study 33315586 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection (2 mL saline and lidocaine)
Number of subjects: 80
Study 33315586 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume injection without corticosteroids
Number of subjects: 80
Study 34668986 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg daily during menstruation
Number of subjects: 40
Study 34668986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33515784 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month mobile intervention based on social cognitive theory including behavioral lessons, adaptive goal-setting, tailored feedback, text messages, and Facebook prompts.
Number of subjects: 280
Study 33515784 — intervention group
Group type: COMPARATOR
Intervention: Self-help control group receiving an activity tracker, mobile app, cellular-enabled scale, individual videochat session, and access to a Facebook group.
Number of subjects: 280
Study 34613828 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent mentor teaching We Can!
Number of subjects: 188
Study 34613828 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent mentor teaching an intervention derived from positive deviance methods
Number of subjects: 188
Study 34613828 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 188
Study 34000843 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Working Alliance Inventory (DWAI)
Number of subjects: 604
Study 34000843 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 604
Study 32682166 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic change complex (ACC) assessment for difference limen for intensity (DLI)
Number of subjects: 30
Study 32682166 — intervention group
Group type: COMPARATOR
Intervention: Standard stimulus using a 1000 Hz stimulus
Number of subjects: 30
Study 34676660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 152
Study 34676660 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy (HT)
Number of subjects: 152
Study 34676660 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 152
Study 32394656 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint embedding therapy
Number of subjects: 210
Study 34791296 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate-containing arms
Number of subjects: 594
Study 34791296 — intervention group
Group type: COMPARATOR
Intervention: Non-tenofovir disoproxil fumarate arms
Number of subjects: 594
Study 34308356 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting reversible contraception (LARC)
Number of subjects: 208
Study 34308356 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting method
Number of subjects: 208
Study 34308356 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 208
Study 34308356 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 208
Study 34308356 — intervention group
Group type: COMPARATOR
Intervention: Sexual activity
Number of subjects: 208
Study 35855818 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented reality-based training (ART)
Number of subjects: 48
Study 35855818 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback training (MVFT)
Number of subjects: 48
Study 35855818 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-based training (TBT)
Number of subjects: 48
Study 35855818 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 34238363 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning education program on lifestyle changes for management of high blood pressure
Number of subjects: 300
Study 34238363 — intervention group
Group type: COMPARATOR
Intervention: Information booklets and general advice
Number of subjects: 300
Study 34238363 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning education program
Number of subjects: 300
Study 33290446 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic prednisone and nasal irrigation with betamethasone, ambroxol and rinazine for 15 days
Number of subjects: 18
Study 33290446 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 18
Study 35685657 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Radiofrequency (RF) therapy
Number of subjects: 100
Study 35685657 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT-A) injection
Number of subjects: 100
Study 34401369 — intervention group
Group type: EXPERIMENTAL
Intervention: epos (emotion-based psycho-oncological online self-help)
Number of subjects: 325
Study 34401369 — intervention group
Group type: COMPARATOR
Intervention: Informational website (control group)
Number of subjects: 325
Study 35130966 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observation therapy (AOT) group observing videos of eccentric exercises prior to performing the exercises.
Number of subjects: 0
Study 35130966 — intervention group
Group type: COMPARATOR
Intervention: Control group observing videos of landscapes prior to performing the eccentric exercises.
Number of subjects: 0
Study 35752215 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-appropriate intervention consisting of problem-solving therapy, behavioral activation, parenting skills training, and parenting support from a self-identified adult
Number of subjects: 242
Study 35752215 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 242
Study 33305660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy (TIC)
Number of subjects: 110
Study 33305660 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor and Aspirin (TIC+ASP)
Number of subjects: 110
Study 34627141 — intervention group
Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL)
Number of subjects: 870
Study 34627141 — intervention group
Group type: EXPERIMENTAL
Intervention: amodiaquine-artesunate (ASAQ)
Number of subjects: 870
Study 34627141 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DHAPQ)
Number of subjects: 870
Study 34627141 — intervention group
Group type: EXPERIMENTAL
Intervention: concomitant medication
Number of subjects: 870
Study 34627141 — intervention group
Group type: EXPERIMENTAL
Intervention: total bilirubin
Number of subjects: 870
Study 34627141 — intervention group
Group type: EXPERIMENTAL
Intervention: alanine aminotransferase
Number of subjects: 870
Study 32106225 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First treatment (rent supplements and mental health support services)
Number of subjects: 414
Study 32106225 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 414
Study 35165925 — intervention group
Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 0
Study 35165925 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 0
Study 33252482 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision respondent-driven sampling (pRDS) with 5 recruitment coupons for high probability individuals
Number of subjects: 1631
Study 33252482 — intervention group
Group type: COMPARATOR
Intervention: Standard respondent-driven sampling (RDS) with 2 recruitment coupons
Number of subjects: 1631
Study 33252482 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision respondent-driven sampling (pRDS)
Number of subjects: 1631
Study 33252482 — intervention group
Group type: COMPARATOR
Intervention: Standard respondent-driven sampling (RDS)
Number of subjects: 1631
Study 32199021 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy (BT) plus Physical Therapy (PT)
Number of subjects: 60
Study 32199021 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy (PT) only
Number of subjects: 60
Study 36075595 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken‐claw needling at Xiaguan (ST 7) combined with intradermal needling, once a day for 6 days, total of 2 courses.
Number of subjects: 60
Study 36075595 — intervention group
Group type: COMPARATOR
Intervention: Oral carbamazepine tablets for 13 days.
Number of subjects: 60
Study 33609476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilavonemab 2000 mg
Number of subjects: 378
Study 33609476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilavonemab 4000 mg
Number of subjects: 378
Study 33609476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study 36026789 — intervention group
Group type: EXPERIMENTAL
Intervention: TensioBot (chatbot)
Number of subjects: 112
Study 36026789 — intervention group
Group type: COMPARATOR
Intervention: Control group (paper annotations)
Number of subjects: 112
Study 34274708 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based physical activity promotion intervention over six months
Number of subjects: 264
Study 34274708 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based physical activity promotion intervention
Number of subjects: 264
Study 33152522 — intervention group
Group type: EXPERIMENTAL
Intervention: PREDID trial (active discopathy)
Number of subjects: 256
Study 33152522 — intervention group
Group type: COMPARATOR
Intervention: Independent cohort (no active discopathy)
Number of subjects: 256
Study 36297495 — intervention group
Group type: EXPERIMENTAL
Intervention: ADV6209 (0.25 mg kg−1)
Number of subjects: 80
Study 36297495 — intervention group
Group type: COMPARATOR
Intervention: Conventional midazolam (0.25 mg kg−1)
Number of subjects: 80
Study 36297495 — intervention group
Group type: EXPERIMENTAL
Intervention: ADV6209
Number of subjects: 80
Study 36297495 — intervention group
Group type: COMPARATOR
Intervention: Conventional midazolam
Number of subjects: 80
Study 36297495 — intervention group
Group type: EXPERIMENTAL
Intervention: ADV6209 and Conventional midazolam
Number of subjects: 80
Study 33044768 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 300 mg/day
Number of subjects: 40
Study 33044768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34486319 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran (40 g per day for 30 days)
Number of subjects: 160
Study 36344969 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoselective sharp enucleation of the prostate (PSEP)
Number of subjects: 154
Study 36344969 — intervention group
Group type: COMPARATOR
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 154
Study 32366796 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT at 260 J
Number of subjects: 27
Study 32366796 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT at 130 J
Number of subjects: 27
Study 32366796 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 J)
Number of subjects: 27
Study 32366796 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT (all doses)
Number of subjects: 27
Study 35092071 — intervention group
Group type: EXPERIMENTAL
Intervention: CenteringPregnancy (CP)
Number of subjects: 2562
Study 34160776 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 23
Study 34160776 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-placebo condition
Number of subjects: 23
Study 33219142 — intervention group
Group type: EXPERIMENTAL
Intervention: rozanolixizumab 7 mg/kg
Number of subjects: 43
Study 33219142 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 43
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral from a lower health facility
Number of subjects: 540
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime parity
Number of subjects: 540
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of herbal medicines in active labour
Number of subjects: 540
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Being married
Number of subjects: 540
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a delivery plan
Number of subjects: 540
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Having an educated partner
Number of subjects: 540
Study 32040542 — intervention group
Group type: EXPERIMENTAL
Intervention: Four or more ANC visits
Number of subjects: 540
Study 33847190 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs
Number of subjects: 40
Study 33847190 — intervention group
Group type: COMPARATOR
Intervention: RLSs
Number of subjects: 40
Study 36440648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care based on the Levine's Conservation Model
Number of subjects: 65
Study 33427009 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning labels
Number of subjects: 722
Study 33427009 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-drinking comments
Number of subjects: 722
Study 33427009 — intervention group
Group type: COMPARATOR
Intervention: No comments, pro-drinking comments, anti-drinking comments, warning labels, or industry responsibility messages
Number of subjects: 722
Study 32505383 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg linzagolix
Number of subjects: 0
Study 32505383 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg linzagolix
Number of subjects: 0
Study 32505383 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg linzagolix
Number of subjects: 0
Study 32505383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32505383 — intervention group
Group type: EXPERIMENTAL
Intervention: linzagolix (doses ≥ 75 mg)
Number of subjects: 0
Study 32505383 — intervention group
Group type: EXPERIMENTAL
Intervention: linzagolix
Number of subjects: 0
Study 87266332 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime (two-dose peroperative regimen)
Number of subjects: 418
Study 87266332 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin and metronidazole (combined peroperative and postoperative for 4 days)
Number of subjects: 418
Study 35427191 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Group (ELEVATE intervention)
Number of subjects: 34
Study 35427191 — intervention group
Group type: COMPARATOR
Intervention: Delay Group (3-month waitlist control)
Number of subjects: 34
Study 35427191 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-trained children
Number of subjects: 34
Study 34304981 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND Clinic (intervention)
Number of subjects: 48
Study 34304981 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (control)
Number of subjects: 48
Study 34106449 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater socioeconomic status
Number of subjects: 400
Study 34106449 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese subgroup
Number of subjects: 400
Study 33068345 — intervention group
Group type: EXPERIMENTAL
Intervention: Scraping on head and face combined with stepping technique of tuina along lower limbs, applied once every 3 days for a total of 10 times.
Number of subjects: 100
Study 33068345 — intervention group
Group type: COMPARATOR
Intervention: Oryzanol tablets and compound vitamin B tablets, 2 tablets each, 3 times daily for 30 days.
Number of subjects: 100
Study 32188793 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFV1
Number of subjects: 2556
Study 34964230 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling + Trichloroacetic Acid (TCA)
Number of subjects: 75
Study 34964230 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling + 5-Fluorouracil (5-FU)
Number of subjects: 75
Study 34964230 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling + Pimecrolimus
Number of subjects: 75
Study 34964230 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 75
Study 34476446 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing technology under three-dimensional reconstruction
Number of subjects: 84
Study 34476446 — intervention group
Group type: COMPARATOR
Intervention: Routine operation
Number of subjects: 84
Study 35863457 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (3 sequential 150 mg doses every 72 hours)
Number of subjects: 219
Study 35863457 — intervention group
Group type: EXPERIMENTAL
Intervention: Oteseconazole/oteseconazole group
Number of subjects: 219
Study 35863457 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole/placebo group
Number of subjects: 219
Study 33876875 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline (3 g/day)
Number of subjects: 54
Study 33876875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 36148578 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour semifluid and 2-hour water fasting protocol ('4+2' protocol)
Number of subjects: 214
Study 36148578 — intervention group
Group type: COMPARATOR
Intervention: Conventional fasting
Number of subjects: 214
Study 33632285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannose supplementation
Number of subjects: 0
Study 33632285 — intervention group
Group type: COMPARATOR
Intervention: No mannose supplementation
Number of subjects: 0
Study 32109881 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Physical Activity (LPA)
Number of subjects: 10000
Study 35363054 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic advanced hybrid closed-loop (AHCL) system
Number of subjects: 112
Study 35363054 — intervention group
Group type: COMPARATOR
Intervention: Medtronic MiniMed™ 670G hybrid closed-loop system (670G)
Number of subjects: 112
Study 35363054 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms (AHCL and 670G)
Number of subjects: 112
Study 34103898 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-8031 20 mg
Number of subjects: 40
Study 34103898 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-8031 30 mg
Number of subjects: 40
Study 34103898 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-8031 40 mg
Number of subjects: 40
Study 34103898 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 intermediate metabolizer
Number of subjects: 40
Study 34103898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35263755 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly lonapegsomatropin 0.24 mg human growth hormone/kg/week
Number of subjects: 146
Study 35263755 — intervention group
Group type: COMPARATOR
Intervention: Daily somatropin therapy
Number of subjects: 146
Study 33125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Eichhornia crassipes
Number of subjects: 7
Study 33125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistia stratiotes
Number of subjects: 7
Study 33125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvinia molesta
Number of subjects: 7
Study 33125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Eichhornia crassipes and Pistia stratiotes
Number of subjects: 7
Study 33125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Eichhornia crassipes and Salvinia molesta
Number of subjects: 7
Study 33125679 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistia stratiotes and Salvinia molesta
Number of subjects: 7
Study 33125679 — intervention group
Group type: COMPARATOR
Intervention: Without plant, treated only with sedimentation
Number of subjects: 7
Study 35813258 — intervention group
Group type: EXPERIMENTAL
Intervention: Mount Sinai Prebiopsy Risk Calculator (MSP-RC)
Number of subjects: 1902
Study 35813258 — intervention group
Group type: COMPARATOR
Intervention: Advanced Neural Networking (ANN)
Number of subjects: 1902
Study 35813258 — intervention group
Group type: COMPARATOR
Intervention: European Randomized Study of Screening for Prostate Cancer Risk Calculator (ERSPC RC)
Number of subjects: 1902
Study 35813258 — intervention group
Group type: COMPARATOR
Intervention: Prostate MRI Outcome Database (PROMOD)
Number of subjects: 1902
Study 33050945 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 160 mg four times a day for up to 14 days
Number of subjects: 20
Study 33050945 — intervention group
Group type: COMPARATOR
Intervention: Placebo in the same dosage as Famotidine
Number of subjects: 20
Study 35956324 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran (30 g/d, containing DF 8.9 g)
Number of subjects: 70
Study 35956324 — intervention group
Group type: COMPARATOR
Intervention: Regular DASH dietary care
Number of subjects: 70
Study 33675624 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ placement of the ulnar nerve in the cubital tunnel
Number of subjects: 58
Study 33675624 — intervention group
Group type: COMPARATOR
Intervention: Anterior transposition of the ulnar nerve
Number of subjects: 58
Study 32020530 — intervention group
Group type: COMPARATOR
Intervention: Pazopanib 800 mg once daily (QD)
Number of subjects: 9
Study 32020530 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg twice daily
Number of subjects: 9
Study 35835336 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube shunt (350‐mm2 Baerveldt glaucoma implant)
Number of subjects: 242
Study 35835336 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC, 0.4 mg/ml for 2 minutes)
Number of subjects: 242
Study 33811803 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administration of medication programme
Number of subjects: 60
Study 33811803 — intervention group
Group type: COMPARATOR
Intervention: Routine medication administration (Control)
Number of subjects: 60
Study 35989964 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle-positive expiratory pressure (PEP)
Number of subjects: 24
Study 35989964 — intervention group
Group type: COMPARATOR
Intervention: Breathing exercises (control group)
Number of subjects: 24
Study 34697401 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 196
Study 34697401 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 196
Study 34697401 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 196